KALA BIO, Inc. (KALA)

KALA BIO Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	-	-	3.89	11.24	6.36
Revenue Growth (YoY)	-	-	-65.37%	76.67%	4.74%
Cost of Revenue	-	-	2.56	4.1	2.67
Gross Profit	-	-	1.33	7.14	3.69
Selling, General & Admin	18.34	20.57	65.04	105.06	81.07
Research & Development	22.09	18.59	17.65	11.52	18.35
Operating Expenses	40.43	39.15	82.69	116.58	99.42
Operating Income	-40.43	-39.15	-81.36	-109.43	-95.73
Interest Expense	-5.78	-5.81	-7.27	-8.38	-8.59
Interest & Investment Income	2.06	2.71	0.66	0.1	0.49
Other Non Operating Income (Expenses)	6.2	3.97	-0.93	-	-
EBT Excluding Unusual Items	-37.96	-38.29	-88.88	-117.71	-103.83
Gain (Loss) on Sale of Assets	-	4.2	47	-	-
Asset Writedown	-	-7.6	-	-	-0.5
Other Unusual Items	-0.55	-0.51	-2.93	1.72	-
Pretax Income	-38.51	-42.2	-44.82	-142.61	-104.33
Net Income	-38.51	-42.2	-44.82	-142.61	-104.33
Net Income to Common	-38.51	-42.2	-44.82	-142.61	-104.33
Shares Outstanding (Basic)	4	2	2	1	1
Shares Outstanding (Diluted)	4	2	2	1	1
Shares Change (YoY)	56.09%	59.94%	15.50%	25.67%	53.11%
EPS (Basic)	-10.15	-17.35	-29.48	-108.32	-99.59
EPS (Diluted)	-10.15	-17.35	-29.48	-108.32	-99.59
Free Cash Flow	-29.59	-28.54	-79.22	-109.12	-92.64
Free Cash Flow Per Share	-7.79	-11.73	-52.10	-82.89	-88.43
Gross Margin	-	-	34.22%	63.55%	57.98%
Operating Margin	-	-	-2090.34%	-973.60%	-1504.73%
Profit Margin	-	-	-1151.64%	-1268.73%	-1639.85%
Free Cash Flow Margin	-	-	-2035.48%	-970.83%	-1456.08%
EBITDA	-40.18	-38.85	-80.82	-108.46	-94.82
D&A For EBITDA	0.26	0.3	0.54	0.98	0.91
EBIT	-40.43	-39.15	-81.36	-109.43	-95.73

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q